AZ SB1085

Pharmacists may independently order, perform, and interpret FDA-approved tests waived under the Clinical Laboratory Improvement Amendments of 1988 pursuant to a statewide written protocol approved by the Arizona State Board of Pharmacy in consultation with the Arizona Medical Board.

Pharmacists may initiate treatment for eligible patients at least 6 years of age who test positive for influenza, group A streptococcus pharyngitis, respiratory illness/disease, or conditions related to public health threats identified by the Department of Health Services.

Pharmacists must use evidence-based clinical guidelines from the Centers for Disease Control and Prevention or Infectious Diseases Society of America and must refer patients to their primary care provider if ineligible or unresponsive to initial treatment.

Pharmacists must notify the patient's identified primary care provider within 72 hours of initiating treatment and within 48 hours of any adverse reactions, maintain treatment records for 7 years, and provide pediatric preventive health care information to minor patients.

Pharmacists may delegate waived testing tasks to licensed pharmacy staff under supervision but cannot delegate clinical judgment decisions, and parental consent is required for treatment of minors.